The creation of each new biotechnology enables a tool, a therapy, or a diagnostic: a molecule, a protein, an app, a platform. And the process underneath isn’t just complex in the science and engineering of it, but in the go to market. So who are the stakeholders in this process? In this podcast (whi
a16z Podcast: Players and Paths for Healthcare Startups

a16z Podcast: Players and Paths for Healthcare Startups
a16z Podcast
0:00
--:--